Bastia 23 mg (Donepezil Hydrochloride)

Adult dose

This medication is taken once daily just before bedtime and can be taken without regard to food. The initial recommended dosage of Donepezil Hydrochloride is 5 mg once daily. This medication reaches a steady state after 15 days of administration and should be taken at 5 mg for 4-6 weeks. After evaluating the clinical response, the dosage can be increased to 10 mg. If increasing to 10 mg daily, observe for gastrointestinal adverse reactions.

This medication is a drug containing Donepezil Hydrochloride, used for the treatment of Alzheimer's dementia symptoms. This medication should not be administered to certain patients. For example, patients with allergies to this medication or its components, pregnant women or women who may become pregnant, and patients with genetic issues such as lactose intolerance should not take this medication. Patients with heart diseases or who are taking non-steroidal anti-inflammatory drugs, patients with a history of asthma or obstructive pulmonary diseases, patients with extrapyramidal disorders such as Parkinson's Disease, and patients allergic to the yellow dye No. 4 contained in this medication should use it cautiously. This medication may cause a slow or irregular heartbeat and can lead to various severe side effects such as peptic ulcers, gastrointestinal bleeding, liver dysfunction, cerebrovascular issues, and muscle problems. If these symptoms occur, immediate consultation with a physician is necessary. Furthermore, while taking this medication, side effects like nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headache, and fatigue may occur, most of which are transient and mild. This medication is approved for use only in patients with Alzheimer's dementia and should not be used for other types of dementia or memory disorders. Treatment should be conducted under the supervision of an experienced physician, and discontinuation should be considered if there is no effect. Patients with heart diseases or electrolyte imbalances are at risk of arrhythmias and may require an electrocardiogram. Additionally, patients with gastrointestinal issues should be cautious of symptom exacerbation. This medication may affect driving or operating machinery, so caution is required at the beginning of treatment or when changing dosages. Women who are pregnant or breastfeeding should avoid taking this medication unless absolutely necessary and should consult a specialist. This medication may interact with multiple drugs, so if taking other medications, it is imperative to inform a physician or pharmacist. In cases of overdose, symptoms such as nausea, vomiting, bradycardia, hypotension, and respiratory depression may occur, and immediate emergency treatment is required; atropine may be used as an antidote. Finally, this medication should be kept out of reach of children and should not be transferred to another container for safety.

Serious side effects

• Syncope
• bradycardia
• heart block
• prolonged QT interval
• myocardial infarction
• heart failure
• peptic ulcer
• perforated duodenal ulcer
• gastrointestinal bleeding
• hepatitis

Mild side effects

• Nausea
• vomiting
• diarrhea
• loss of appetite
• headache
• fatigue
• weakness
• fever
• dizziness
• insomnia

This medication should be stored in a well-closed container that is airtight, at a temperature between 1 degrees to 30 degrees Celsius at room temperature. This storage will help maintain the medication's effectiveness over time.

Appearance

Red, biconvex, round film-coated tablet

Package unit

30 tablets/bottle